Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on May 23, 2025
Sample Sale Spectacle: Murray Hill Optical Launches with Weeklong Event Featuring Deep Discounts and Designer Finds
EIN Presswire
·
May 23, 2025
Score designer frames up to 80% off during Murray Hill Optical’s grand opening sample sale, May 28–June 4 at 500 3rd Ave, NYC. Style, prizes, and vision await! NEW YORK, NY, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- A Fresh Start, A Limited-Time …
AI CERTs™ and Michigan Healthcare Academy Partner to Advance AI Education for Future Healthcare Professionals
EIN Presswire
·
May 23, 2025
Through this collaboration, MHA will offer access to AI CERTs’ certification programs such as AI+ Healthcare™ and AI+ Ethics™. NEW YORK, NY, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- AI CERTs™, a global leader in role-based certifications for …
BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.
GlobeNewswire
·
May 23, 2025
Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced it has signed a definitive share exchange agreement with Streamex …
IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
May 23, 2025
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …
ALIGNERCO Introduces New Cleansing Tablets for Aligners, Retainers & Dentures
EIN Presswire
·
May 23, 2025
ALIGNERCO’s Cleansing Tablets offer a fast-acting, deep-cleaning solution to eliminate bacteria, stains, and odors from oral appliances in just 5 minutes. HICKSVILLE, NY, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- ALIGNERCO, a pioneer in …
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
GlobeNewswire
·
May 23, 2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 23, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”) announced today that its shareholders voted in …
Information on the total number of voting rights and shares
GlobeNewswire
·
May 23, 2025
Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), May 23, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext …
Informations sur le nombre total de droits de vote et d'actions
GlobeNewswire
·
May 23, 2025
Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 23 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA ( …
Polyrizon Announces Receipt of Nasdaq Delisting Notice
GlobeNewswire
·
May 23, 2025
Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a …
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
GlobeNewswire
·
May 23, 2025
HOUSTON, May 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 21, 2025, which indicated that the Company was not in compliance with Nasdaq …
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
GlobeNewswire
·
May 23, 2025
IRVINE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, …
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
GlobeNewswire
·
May 23, 2025
PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that …
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
GlobeNewswire
·
May 23, 2025
Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, …
Boundless Bio Announces Portfolio Prioritization and Runway Extension
GlobeNewswire
·
May 23, 2025
Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first half of 2028, through expected proof-of-concept clinical …
Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
GlobeNewswire
·
May 23, 2025
WARREN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced a planned expansion of TVGN 489’s target population to include patients 65 and older. As previously reported in October 2024, …
Ace Therapeutics Launches Validated Disease Models Aiming to Elevate Gastroenterology Research to New Heights
EIN Presswire
·
May 23, 2025
Ace Therapeutics recently unveiled a comprehensive suite of well-validated disease models tailored for gastroenterology lab research. NEW YORK, NY, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- Ace Therapeutics, a preclinical contract research …
Cross Medical Group Introduces HydraFacial Treatments for Advanced Skin Rejuvenation
GlobeNewswire
·
May 23, 2025
PHILADELPHIA and VILLANOVA, Pa., May 23, 2025 (GLOBE NEWSWIRE) -- Cross Medical Group is pleased to announce that HydraFacial treatments are now available at the practice. A HydraFacial at their Philadelphia and Villanova offices, which is sometimes …
U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
GlobeNewswire
·
May 23, 2025
FDA’s approval of YUTREPIA paves the way for prescribers to add a new treatment option for patients with PAH and PH-ILD YUTREPIA is designed to enhance deep-lung delivery with an easy-to-use device requiring low inspiratory effort Demonstrated tolerability …
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
GlobeNewswire
·
May 23, 2025
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (“MediPharm”, the “Company”, or “we”), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareholders with information related to three of the …
Mind Body Peak Performance Rebrands to ‘High Performance Longevity’ Podcast, Integrating Biohacking with Ancestral Wisdom
GlobeNewswire
·
May 23, 2025
Austin, TX, May 23, 2025 (GLOBE NEWSWIRE) -- Outliyr, a performance health brand known for combining modern biohacking with ancestral wisdom, has rebranded its podcast—formerly Mind Body Peak Performance—as High Performance Longevity to reflect a deeper …